Doximity PE Ratio 2020-2025 | DOCS
Current and historical p/e ratio for Doximity (DOCS) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Doximity PE ratio as of January 13, 2026 is 32.06.
| Doximity PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-14 | 40.27 | 31.96 | |
| 2025-09-30 | 73.15 | $1.26 | 58.06 |
| 2025-06-30 | 61.34 | $1.17 | 52.43 |
| 2025-03-31 | 58.03 | $1.11 | 52.28 |
| 2024-12-31 | 53.39 | $1.00 | 53.39 |
| 2024-09-30 | 43.57 | $0.87 | 50.08 |
| 2024-06-30 | 27.97 | $0.80 | 34.96 |
| 2024-03-31 | 26.91 | $0.72 | 37.38 |
| 2023-12-31 | 28.04 | $0.66 | 42.48 |
| 2023-09-30 | 21.22 | $0.58 | 36.59 |
| 2023-06-30 | 34.02 | $0.55 | 61.85 |
| 2023-03-31 | 32.38 | $0.52 | 62.27 |
| 2022-12-31 | 33.56 | $0.55 | 61.02 |
| 2022-09-30 | 30.22 | $0.65 | 46.49 |
| 2022-06-30 | 34.82 | $0.70 | 49.74 |
| 2022-03-31 | 52.09 | $0.69 | 75.49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $7.787B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.560B | 43.44 |
| Tempus AI (TEM) | United States | $11.946B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.330B | 59.63 |
| IRhythm Technologies (IRTC) | United States | $5.008B | 0.00 |
| Hinge Health (HNGE) | United States | $3.710B | 0.00 |
| Privia Health (PRVA) | United States | $2.835B | 177.31 |
| Heartflow (HTFL) | United States | $2.731B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.687B | 44.45 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.306B | 47.15 |
| Azenta (AZTA) | United States | $1.771B | 72.64 |
| Enovis (ENOV) | United States | $1.410B | 7.41 |
| Schrodinger (SDGR) | United States | $1.349B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.111B | 0.00 |
| Phreesia (PHR) | United States | $1.000B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Talkspace (TALK) | United States | $0.659B | 132.67 |
| Standard BioTools (LAB) | United States | $0.627B | 0.00 |
| Claritev (CTEV) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.448B | 0.00 |
| Carlsmed (CARL) | United States | $0.379B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.355B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.268B | 0.00 |
| CapsoVision (CV) | United States | $0.266B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.207B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.178B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.124B | 6.81 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| HeartBeam (BEAT) | United States | $0.083B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.045B | 0.00 |
| 111 (YI) | China | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |